<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02418247</url>
  </required_header>
  <id_info>
    <org_study_id>NCCCTS13-671</org_study_id>
    <secondary_id>1410650-1,2</secondary_id>
    <nct_id>NCT02418247</nct_id>
  </id_info>
  <brief_title>Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer</brief_title>
  <official_title>Phase â…¡ Non-randomized Multicenter Controlled Trial About Effect of Remnant Ablation Therapy on the Recurrence in Low-risk Differentiated Thyroid Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers investigated the rate of biochemical remission in patients without
      radioactive iodine therapy compared to patients with low dose radioactive iodine treatment in
      differentiated thyroid cancer patients who underwent total thyroidectomy.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 2013</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biochemical Remission Rate</measure>
    <time_frame>within 1 year since first thyroid hormone withdrawal regardless of radioactive iodine administration</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">556</enrollment>
  <condition>Thyroid Neoplasms</condition>
  <arm_group>
    <arm_group_label>low dose RAI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low dose RAI (radioactive iodine I-131, 30mCi) will be given to ablate remnant thyroid tissue.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diagnostic RAI</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Diagnostic RAI (radioactive iodine I-123, 2-6mCi) will be given to achieve postRAI scan.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>I131</intervention_name>
    <arm_group_label>low dose RAI</arm_group_label>
    <other_name>low dose RAI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>I123</intervention_name>
    <arm_group_label>diagnostic RAI</arm_group_label>
    <other_name>diagnostic RAI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with differentiated thyroid cancer

          -  recently underwent total thyroidectomy (within 6 months)

          -  pathological criteria

               1. T1bN0 : Tumor size 1-2cm with no microscopic extension with multifocality (within
                  three foci)

               2. T3N0 : Tumor size &lt;=2cm with microscopic extension (less than strap muscle)

               3. T1-3N1a : 3 or less micrometastatic lymph node

        Exclusion Criteria:

          -  differentiated thyroid cancer with aggressive variant, poorly differentiated thyroid
             cancer, medullary thyroid cancer, anaplastic thyroid cancer

          -  gross extension (strap muscle or more)

          -  thyroid cancer with distant metastasis

          -  previous remote history of thyroid cancer surgery

          -  history of cervical external beam radiation therapy

          -  previous history of comorbid cancer within 5 years

          -  renal insufficiency (Ccr &lt;30ml/min)

          -  women with pregnancy or breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eun Kyung Lee, M.D.,Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>National Cancer Center, Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daejun</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center, Korea</name>
      <address>
        <city>Goyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Boramae Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Sungnam</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2015</study_first_submitted>
  <study_first_submitted_qc>April 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2015</study_first_posted>
  <last_update_submitted>January 18, 2017</last_update_submitted>
  <last_update_submitted_qc>January 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Eun Kyung Lee</investigator_full_name>
    <investigator_title>M.D., Ph.D.</investigator_title>
  </responsible_party>
  <keyword>radioactive iodine therapy</keyword>
  <keyword>ablation</keyword>
  <keyword>thyroid cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iodine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

